Indeed, Fisher’s exact test supports a statistically significant association of abnormal methylation of MMP24 and MMP25 promoters in tumor samples with their attribution to the hypermethylated BC subtype with p = 0.033 for MMP24 and p = 0.002 for MMP25. Here, MMP24 is linked to breast cancer.